Device Week, Dec 10, 2021 – Early Alzheimer’s Diagnostic, And Cardiac Pacing Breakthroughs

In this edition of Device Week, Medtech Insight’s Marion Webb talks to UK-based reporter Barnaby Pickering about Cognetivity’s FDA approved diagnostic tool for Alzheimer’s. The company hopes that by providing earlier diagnosis, cost savings in the trillions of dollars can be made. Reed Miller also discusses Boston Scientific’s new “Modular” cardiac rhythm management system. They launched the trial of their Modular system that includes both a subcutaneous ICD and a leadless pacemaker, with positive results expected.

Medtech Insight articles addressing topics discussed in this episode:

- Exec Chat: Cognetivity’s Simple Brain Test Could Unlock Trillions In Health Care Savings
- Boston Scientific Advances First ‘Modular’ Cardiac Rhythm Management System